Rhythm Metabolic's Series A Round

Rhythm Metabolic raised a round of funding on August 12, 2015.

Rhythm is a biopharmaceutical company developing peptide therapeutics for the treatment of gastrointestinal (GI) diseases and obesity, including obesity caused by genetic deficiencies in the MC4 pathw…

Articles about Rhythm Metabolic's Series A Round: